SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Swift who wrote (2408)4/17/1999 7:27:00 PM
From: wolfdog2  Read Replies (1) of 10280
 
Bob, I'm sure the directors selling didn't help. But I think that the decline in the stock price was more a case of reality catching up with the stock. Sure SEPR has a full pipeline of interesting products, but the company won't be profitable for some time and is in fact incurring huge quarterly losses. Unless you consider a ~$30 million loss in the last quarter small. What's more the company has not as yet demonstrated that they can field a sales force capable of selling Xopenex or anything else. In addition, while it seems fairly certain that the company will have some big winners, it may also have some disappoints as well.

I know most on this board think the next move is up for the stock. However, if the market weakens, it wouldn't surprise me to see most of the run from the $50-$60 level erased.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext